Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,260.00
-105.00 (-2.41%)
At close: Dec 5, 2025
-44.24%
Market Cap 211.08B
Revenue (ttm) 66.40B
Net Income (ttm) -28.37B
Shares Out 49.55M
EPS (ttm) -567.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 270,538
Average Volume 283,751
Open 4,300.00
Previous Close 4,365.00
Day's Range 4,115.00 - 4,340.00
52-Week Range 4,110.00 - 13,600.00
Beta -0.85
RSI 34.05
Earnings Date Nov 14, 2025

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as well as lights for parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps, LED flat lamps, LED... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 307
Stock Exchange KOSDAQ
Ticker Symbol 082800
Full Company Profile

Financial Performance

In 2024, Vivozon Pharmaceutical's revenue was 87.60 billion, an increase of 22.83% compared to the previous year's 71.32 billion. Losses were -9.98 billion, 197.3% more than in 2023.

Financial Statements

News

There is no news available yet.